Showing results (4491-4500 of 8,684) with videos related to
Sort By:
Pageof 869
Bioorganic Chemistry|April 3, 2022
Synthesis, bio-physical and anti-leishmanial studies of some novel indolo[3,2-a]phenanthridine derivativesJeet Banerjee, Anindita Bhattacharjee, Arunima Biswas, et al.Bioorganic Chemistry|March 24, 2022
Targeting the HVEM protein using a fragment of glycoprotein D to inhibit formation of the BTLA/HVEM complexKatarzyna Kuncewicz, Claire Battin, Katarzyna Węgrzyn, et al.Bioorganic Chemistry|March 29, 2022
Cytotoxic diterpenoid dimer containing an intricately caged core from Euphorbia fischerianaZhen-Long Yu, Mei-Rong Zhou, Wei-Yi Wang, et al.Bioorganic Chemistry|April 2, 2022
Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitorsAmit Kumar, Kiran Siwach, Tanmay Rom, et al.Bioorganic Chemistry|March 11, 2022
Rational design, synthesis and activities of hydroxylated chalcones as highly potent dual functional agents against Alzheimer's diseaseYuanyuan Liu, Chu Han, Rongji Dai, et al.Bioorganic Chemistry|March 11, 2022
Novel 18β-glycyrrhetinic acid derivatives as a Two-in-One agent with potent antimicrobial and anti-inflammatory activityBorong Tu, Jinfeng Liang, Yi Ou, et al.Bioorganic Chemistry|March 6, 2022
Targeting Ship2-Sam with peptide ligands: Novel insights from a multidisciplinary approachMarian Vincenzi, Flavia Anna Mercurio, Concetta Di Natale, et al.Bioorganic Chemistry|March 7, 2022
Cytotoxic triterpene and steroidal glycosides from the seeds of Digitalis purpurea and the synergistic cytotoxicity of steroidal glycosides and etoposide in SBC-3 cellsYukiko Matsuo, Hiroko Tsuchihashi, Kazuhiro Takatori, et al.Bioorganic Chemistry|March 7, 2022
Design, synthesis, molecular docking and molecular dynamics studies of novel triazolothiadiazine derivatives containing furan or thiophene rings as anticancer agentsDerya Osmaniye, Şevval Karaca, Berkant Kurban, et al.Bioorganic Chemistry|March 7, 2022
Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disordersSukhbir Singh, Ajmer Singh Grewal, Rupanshi Grover, et al.Pageof 869